Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138– CD34– tumor stem-like cells in multiple myeloma-bearing mice
Cuiping Yang,1,3,* Jing Wang,2,* Dengyu Chen,1,* Junsong Chen,1 Fei Xiong,4 Hongyi Zhang,1 Yunxia Zhang,2 Ning Gu,4 Jun Dou11Department of Pathogenic Biology and Immunology, Medical School, 2Department of Gynecology and Obstetrics, Zhongda Hospital, Southeast University, Nanjing, 3Departmen...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/318e3fe5089b4e0980e9635dff287020 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:318e3fe5089b4e0980e9635dff287020 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:318e3fe5089b4e0980e9635dff2870202021-12-02T00:40:15ZPaclitaxel-Fe3O4 nanoparticles inhibit growth of CD138– CD34– tumor stem-like cells in multiple myeloma-bearing mice1176-91141178-2013https://doaj.org/article/318e3fe5089b4e0980e9635dff2870202013-04-01T00:00:00Zhttp://www.dovepress.com/paclitaxel-fe3o4-nanoparticles-inhibit-growth-of-cd138--cd34--tumor-st-a12734https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Cuiping Yang,1,3,* Jing Wang,2,* Dengyu Chen,1,* Junsong Chen,1 Fei Xiong,4 Hongyi Zhang,1 Yunxia Zhang,2 Ning Gu,4 Jun Dou11Department of Pathogenic Biology and Immunology, Medical School, 2Department of Gynecology and Obstetrics, Zhongda Hospital, Southeast University, Nanjing, 3Department of Pathogenic Biology and Immunology, School of Basic Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang, 4School of Biological Science and Medical Engineering, Southeast University, Nanjing, People’s Republic of China*These authors contributed equally to this workBackground: There is growing evidence that CD138– CD34– cells may actually be tumor stem cells responsible for initiation and relapse of multiple myeloma. However, effective drugs targeted at CD138– CD34– tumor stem cells are yet to be developed. The purpose of this study was to investigate the inhibitory effect of paclitaxel-loaded Fe3O4 nanoparticles (PTX-NPs) on CD138– CD34– tumor stem cells in multiple myeloma-bearing mice.Methods: CD138– CD34– cells were isolated from a human U266 multiple myeloma cell line using an immune magnetic bead sorting method and then subcutaneously injected into mice with nonobese diabetic/severe combined immunodeficiency to develop a multiple myeloma-bearing mouse model. The mice were treated with Fe3O4 nanoparticles 2 mg/kg, paclitaxel 4.8 mg/kg, and PTX-NPs 0.64 mg/kg for 2 weeks. Tumor growth, pathological changes, serum and urinary interleukin-6 levels, and molecular expression of caspase-3, caspase-8, and caspase-9 were evaluated.Results: CD138– CD34– cells were found to have tumor stem cell characteristics. All the mice developed tumors in 40 days after injection of 1 × 106 CD138– CD34– tumor stem cells. Tumor growth in mice treated with PTX-NPs was significantly inhibited compared with the controls (P < 0.005), and the groups that received nanoparticles alone (P < 0.005) or paclitaxel alone (P < 0.05). In addition, the PTX-NPs markedly inhibited interleukin-6 secretion, increased caspase-8, caspase-9, and caspase-3 expression, and induced apoptosis of tumor cells in the treated mice.Conclusion: PTX-NPs proved to be a potent anticancer treatment strategy that may contribute to targeted therapy for multiple myeloma tumor stem cells in future clinical trials.Keywords: multiple myeloma, tumor stem cells, Fe3O4 nanoparticles, paclitaxelYang CWang JChen DChen JXiong FZhang HZhang YGu NDou JDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2013, Iss default, Pp 1439-1449 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Yang C Wang J Chen D Chen J Xiong F Zhang H Zhang Y Gu N Dou J Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138– CD34– tumor stem-like cells in multiple myeloma-bearing mice |
| description |
Cuiping Yang,1,3,* Jing Wang,2,* Dengyu Chen,1,* Junsong Chen,1 Fei Xiong,4 Hongyi Zhang,1 Yunxia Zhang,2 Ning Gu,4 Jun Dou11Department of Pathogenic Biology and Immunology, Medical School, 2Department of Gynecology and Obstetrics, Zhongda Hospital, Southeast University, Nanjing, 3Department of Pathogenic Biology and Immunology, School of Basic Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang, 4School of Biological Science and Medical Engineering, Southeast University, Nanjing, People’s Republic of China*These authors contributed equally to this workBackground: There is growing evidence that CD138– CD34– cells may actually be tumor stem cells responsible for initiation and relapse of multiple myeloma. However, effective drugs targeted at CD138– CD34– tumor stem cells are yet to be developed. The purpose of this study was to investigate the inhibitory effect of paclitaxel-loaded Fe3O4 nanoparticles (PTX-NPs) on CD138– CD34– tumor stem cells in multiple myeloma-bearing mice.Methods: CD138– CD34– cells were isolated from a human U266 multiple myeloma cell line using an immune magnetic bead sorting method and then subcutaneously injected into mice with nonobese diabetic/severe combined immunodeficiency to develop a multiple myeloma-bearing mouse model. The mice were treated with Fe3O4 nanoparticles 2 mg/kg, paclitaxel 4.8 mg/kg, and PTX-NPs 0.64 mg/kg for 2 weeks. Tumor growth, pathological changes, serum and urinary interleukin-6 levels, and molecular expression of caspase-3, caspase-8, and caspase-9 were evaluated.Results: CD138– CD34– cells were found to have tumor stem cell characteristics. All the mice developed tumors in 40 days after injection of 1 × 106 CD138– CD34– tumor stem cells. Tumor growth in mice treated with PTX-NPs was significantly inhibited compared with the controls (P < 0.005), and the groups that received nanoparticles alone (P < 0.005) or paclitaxel alone (P < 0.05). In addition, the PTX-NPs markedly inhibited interleukin-6 secretion, increased caspase-8, caspase-9, and caspase-3 expression, and induced apoptosis of tumor cells in the treated mice.Conclusion: PTX-NPs proved to be a potent anticancer treatment strategy that may contribute to targeted therapy for multiple myeloma tumor stem cells in future clinical trials.Keywords: multiple myeloma, tumor stem cells, Fe3O4 nanoparticles, paclitaxel |
| format |
article |
| author |
Yang C Wang J Chen D Chen J Xiong F Zhang H Zhang Y Gu N Dou J |
| author_facet |
Yang C Wang J Chen D Chen J Xiong F Zhang H Zhang Y Gu N Dou J |
| author_sort |
Yang C |
| title |
Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138– CD34– tumor stem-like cells in multiple myeloma-bearing mice |
| title_short |
Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138– CD34– tumor stem-like cells in multiple myeloma-bearing mice |
| title_full |
Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138– CD34– tumor stem-like cells in multiple myeloma-bearing mice |
| title_fullStr |
Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138– CD34– tumor stem-like cells in multiple myeloma-bearing mice |
| title_full_unstemmed |
Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138– CD34– tumor stem-like cells in multiple myeloma-bearing mice |
| title_sort |
paclitaxel-fe3o4 nanoparticles inhibit growth of cd138– cd34– tumor stem-like cells in multiple myeloma-bearing mice |
| publisher |
Dove Medical Press |
| publishDate |
2013 |
| url |
https://doaj.org/article/318e3fe5089b4e0980e9635dff287020 |
| work_keys_str_mv |
AT yangc paclitaxelfe3o4nanoparticlesinhibitgrowthofcd138ndashnbspcd34ndashtumorstemlikecellsinmultiplemyelomabearingmice AT wangj paclitaxelfe3o4nanoparticlesinhibitgrowthofcd138ndashnbspcd34ndashtumorstemlikecellsinmultiplemyelomabearingmice AT chend paclitaxelfe3o4nanoparticlesinhibitgrowthofcd138ndashnbspcd34ndashtumorstemlikecellsinmultiplemyelomabearingmice AT chenj paclitaxelfe3o4nanoparticlesinhibitgrowthofcd138ndashnbspcd34ndashtumorstemlikecellsinmultiplemyelomabearingmice AT xiongf paclitaxelfe3o4nanoparticlesinhibitgrowthofcd138ndashnbspcd34ndashtumorstemlikecellsinmultiplemyelomabearingmice AT zhangh paclitaxelfe3o4nanoparticlesinhibitgrowthofcd138ndashnbspcd34ndashtumorstemlikecellsinmultiplemyelomabearingmice AT zhangy paclitaxelfe3o4nanoparticlesinhibitgrowthofcd138ndashnbspcd34ndashtumorstemlikecellsinmultiplemyelomabearingmice AT gun paclitaxelfe3o4nanoparticlesinhibitgrowthofcd138ndashnbspcd34ndashtumorstemlikecellsinmultiplemyelomabearingmice AT douj paclitaxelfe3o4nanoparticlesinhibitgrowthofcd138ndashnbspcd34ndashtumorstemlikecellsinmultiplemyelomabearingmice |
| _version_ |
1718403545947963392 |